COMMUNIQUÉS West-GlobeNewswire

Adverum Biotechnologies to Present at Upcoming Investor Conferences

26/02/2018 - 15:01

MENLO PARK, Calif., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM ), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, announced [...]

REVA Announces CE Mark and First Implant of the Fantom Encore Bioresorbable Scaffold

26/02/2018 - 15:00

SAN DIEGO, Feb. 26, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, announces CE Mark of the 2.5 millimeter [...]

Proximity Systems Announces New UV-Clean Self-Disinfecting Technology

26/02/2018 - 15:00

TOMBALL, Texas, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Proximity Systems, Inc., the leading provider of innovative technology furniture solutions to healthcare , today announced its own Proximity UV-Clean self-disinfecting [...]

Adverum Biotechnologies Announces Completion of Dosing of First Cohort of Patients in the ADVANCE Phase 1/2 Clinical Trial of ADVM-043 Gene Therapy for A1AT Deficiency

26/02/2018 - 15:00

-- Data Monitoring Committee Recommends Proceeding to the Second Cohort -- -- Company Expects to Report Preliminary Data in the Second Half of 2018 -- MENLO PARK, Calif., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Adverum [...]

Novo Nordisk A/S: Election of employee representatives to the Board of Directors of Novo Nordisk A/

26/02/2018 - 14:36

Bagsværd, 26 February 2018 - The employees of Novo Nordisk A/S have conducted the election of employee representatives to the Board of Directors of Novo Nordisk A/S. The following members were elected for the next four [...]

Teladoc Earns Surescripts Certification for Medication History Services

26/02/2018 - 14:35

PURCHASE, NY, Feb. 26, 2018 (GLOBE NEWSWIRE) -- HIMSS Booth #3860 - Teladoc , Inc. (NYSE: TDOC ) the world’s largest and most trusted provider of virtual care delivery services, announced today that it has been [...]

Auris Medical to Host Key Opinion Leader Call Focused on Keyzilen® Tinnitus Program on March 5, 2018

26/02/2018 - 14:31

Zug, Switzerland, February 26, 2018 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, today announced [...]

Fortress Biotech Announces Aevitas Therapeutics Enters Sponsored Research Agreement with the University of Massachusetts Medical School to Advance AAV Gene Therapies

26/02/2018 - 14:30

SRA with lab of Guangping Gao, Ph.D., to explore construct optimization in AAV gene therapies for complement-mediated diseases Dr. Gao to serve as first member of Aevitas’ recently launched scientific advisory board NEW [...]

Hemispherx To Supply Ampligen for Pancreatic Cancer Patients in Canada Under Special Access Program

26/02/2018 - 14:30

ORLANDO, Fla., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB) said it is expanding its partnership with myTomorrows to supply Ampligen® for pancreatic cancer patients in Canada under a [...]

Marrone Bio Innovations and Groundwork BioAg Bio-stacked Microbial Seed Treatments Result in Increased Corn and Soybean Yields for the Second Field Trial Season

26/02/2018 - 14:30

DAVIS, Calif. and MOSHAV MAZOR, Israel, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider of bio-based pest management and plant health products for agriculture, [...]

Horizon Blue Cross Blue Shield of New Jersey to Cover Interpace’s Molecular Thyroid Tests

26/02/2018 - 14:30

PARSIPPANY, N.J., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG ) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides clinically [...]

Nephros Reports 2017 Fourth Quarter and Full Year Financial Results and Provides Corporate Update

26/02/2018 - 14:10

SOUTH ORANGE, N.J., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid- [...]

Avid Bioservices Announces Resignation of Chief Financial Officer

26/02/2018 - 14:05

TUSTIN, Calif., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO ) (NASDAQ: CDMOP ), a company working to improve patient lives by providing high quality biologics manufacturing services to [...]

Novo Nordisk A/S - Share repurchase programme

26/02/2018 - 14:03

Bagsværd, Denmark, 26 February 2018 - On 5 February 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]

Medtronic Receives FDA Approval for New Arm Indication for Guardian(TM) Sensor 3 - Further Enhancing the MiniMed(TM) 670G Hybrid Closed Loop Experience

26/02/2018 - 14:01

DUBLIN- February 26, 2018 - Medtronic plc (NYSE: MDT ), the global leader in medical technology, today announced that the U.S. Food and Drug Administration (FDA) has approved a new arm indication for the Guardian(TM) [...]

Neos Therapeutics Launches Adzenys ER™ (amphetamine) Extended-Release Oral Suspension in U.S. for the Treatment of ADHD in Patients 6 Years and Older

26/02/2018 - 14:00

DALLAS and FORT WORTH, Texas, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS ), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR [...]

Catalyst Biosciences Announces Manufacturing Agreement with AGC Biologics for Subcutaneous Factor IX Product CB 2679d

26/02/2018 - 14:00

Catalyst plans to initiate a Phase 2b study of CB 2679d in Q3 2018 SOUTH SAN FRANCISCO, Calif., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO ), a clinical-stage biopharmaceutical company [...]

Vericel to Present at the 13th Annual Canaccord Genuity Musculoskeletal Conference

26/02/2018 - 14:00

CAMBRIDGE, Mass., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL ), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, [...]

K2M and International Spine Study Group Foundation Collaborate to Advance Data Management Using BACS®

26/02/2018 - 14:00

LEESBURG, Va., Feb. 26, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three- [...]